000 06151cam a2200697 i 4500
001 ocn868920150
003 OCoLC
005 20221128212459.0
006 m d
007 cr |||||||||||
008 131018s2014 nyu ob 001 0 eng
010 _a 2020684995
040 _aDLC
_beng
_erda
_cDLC
_dYDXCP
_dN$T
_dOCLCF
_dEBLCP
_dD6H
_dAU@
_dSTF
_dE7B
015 _aGBB3B6603
_2bnb
016 7 _a016585516
_2Uk
019 _a869343263
_a900416145
_a918624231
_a923673589
_a928195329
_a982334814
_a982425747
020 _a9781629485171
_q(eBook)
020 _a1629485179
020 _z9781629485140
_q(hbk.)
020 _z1629485144
_q(hbk.)
035 _a669788
_b(N$T)
035 _a(OCoLC)868920150
_z(OCoLC)869343263
_z(OCoLC)900416145
_z(OCoLC)918624231
_z(OCoLC)923673589
_z(OCoLC)928195329
_z(OCoLC)982334814
_z(OCoLC)982425747
042 _apcc
060 4 _aWJ 342
072 7 _aHEA
_x039000
_2bisacsh
072 7 _aMED
_x014000
_2bisacsh
072 7 _aMED
_x022000
_2bisacsh
072 7 _aMED
_x112000
_2bisacsh
072 7 _aMED
_x045000
_2bisacsh
049 _aMAIN
245 0 0 _aChronic kidney disease :
_bsignssymptoms, management options and potential complications
_c
_h[E-Book]
264 1 _aNew York :
_bNova Science Publishers,
_c[2014]
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
490 1 _aNephrology research and clinical developments
504 _aIncludes bibliographical references and index.
588 _aDescription based on print version record; title from PDF title page, viewed (07/16/2020).
505 0 _aCHRONIC KIDNEY DISEASE SIGNS/SYMPTOMS, MANAGEMENT OPTIONS AND POTENTIAL COMPLICATIONS; CHRONIC KIDNEY DISEASE SIGNS/SYMPTOMS, MANAGEMENT OPTIONS AND POTENTIAL COMPLICATIONS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Section A: Chronic Kidney Disease in the General Population; Chapter I Signs and Symptoms of Chronic Kidney Disease; Abstract; 1. Introduction; 2. Definition; 3. Symptoms of CKD; 3.1. General Symptoms; 3.1.1. Anorexia; 3.1.2. Cachexia; 3.1.3. Malaise; 3.2. Cardiovascular; 3.3. Pulmonary; 3.4. Gastrointestinal; 3.5. Genitourinary; 3.6. Hematological.
505 8 _a3.7. Neurological3.7.1. Restless Leg Syndrome (RLS) and Periodic Limb Movement (PLM) disorder; 3.8. Skin; 3.9. Psychiatric; 4. Signs of CKD; References; Chapter II Complications of Chronic Kidney Disease; Abstract; 1. Anemia; Pathogenesis; i. Erythropoietin Deficiency; ii. Iron Deficiency; iii. Hepcidin; iv. Chronic Inflammation, Infections and Oxidative stress; v. Secondary Hyperparathyroidism; Incidence and Prevalence; Diagnosis; 2. Blood and Immune Disorders in Chronic Kidney Disease; 2.1. Bleeding Diathesis in Uremia; Pathogenesis; Clinical Manifestations; Diagnosis.
505 8 _a2.2. Heparin Induced ThrombocytopeniaIncidence; Pathogenesis; Clinical Manifestations; Diagnosis; 2.3. Thrombotic Events; 2.4. Immune Dysfunction in Uremia; 3. Cardiovascular Disease; Epidemiology; Risk Factors; i. Conventional Risk Factors; ia. Hypertension; ib. Diabetes Mellitus; ic. Dyslipidemia; id. Insulin Resistance; ie. Smoking; ii. Non-conventional Risk Factors; iia. Anemia; iib. Oxidative stress; iic. Inflammation; iid. Hyperhomocysteinemia and endothelial dysfunction; iie. Advanced Glycation End Products; iii. Other Risk Factors; Clinical Manifestations; Diagnosis.
505 8 _a4. Bone and Mineral Metabolism in CKDPathogenesis; a. High Turnover Bone Disease; Abnormalities of Calcium Homeostasis; Abnormalities in Phosphate Homeostasis; Abnormalities of Vitamin D Homeostasis; Clinical Manifestations of High Turnover Bone Disease; b. Low Turnover Bone Disease; Diagnosis of Renal Bone Disease; 5. Acid Base Disturbances in CKD; Pathogenesis; Uremic Acidosis and Nutritional status; Uremic Acidosis and Renal Osteodystrophy; Uremic Acidosis and Cardiovascular Disease; 6. Neuropsychological Manifestations in Chronic Kidney Disease; 6.1. Uremic Encephalopathy; Pathogenesis.
505 8 _aClinical ManifestationsDiagnosis; 6.2. Peripheral Neuropathy; Mononeuropathy; Polyneuropathy; 6.3. Autonomic Neuropathy; 6.4. Neurologic Syndromes Associated with Renal Replacement Therapy; Dialysis Disequilibrium Syndrome; Dialysis Encephalopathy; Restless Leg Syndrome; 6.5. Sleep Disorders; Sleep Disordered Breathing (SDB) and Obstructive Sleep Apnea (OSA); Excessive Daytime Sleepiness (EDS); 6.6. Psychological Manifestations; References; Chapter III Treatment of Chronic Kidney Disease Complications; Abstract; I. Anemia; Historical Background; Erythropoiesis Stimulating Agents (ESAs).
520 _aChronic kidney disease is a non-communicable disease that has experienced a global surge in incidence and prevalence over the past few decades, and it has been increasingly considered a major contributor to the global disease burden and mortality. In prior years, most of the awareness and treatment of patients with chronic kidney disease, particularly in the developed world, had focused on patients with end stage renal disease, one of the potential outcomes of chronic kidney disease. More recent epidemiological data has shown that the majority of the burden of chronic kidney disease occurs in.
590 _aMaster record variable field(s) change: 050, 082
650 0 _aChronic renal failure.
650 0 _aKidneys
_xDiseases.
650 2 _aRenal Insufficiency, Chronic.
700 1 _aBalogun, Rasheed Abiodun,
_eeditor.
700 1 _aAbdel-Rahman, Emaad,
_eeditor.
700 1 _aBalogun, Seki A.,
_eeditor.
830 0 _aNephrology research and clinical developments series.
856 4 0 _uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=669788
_yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
938 _aYBP Library Services
_bYANK
_n11319969
938 _aEBSCOhost
_bEBSC
_n669788
938 _aebrary
_bEBRY
_nebr10812508
938 _aProQuest Ebook Central
_bEBLB
_nEBL3023561
942 _n0
994 _a92
_bN$T
999 _c91530
_d91530